ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 615035 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 615035; 2) Community: the network communities that were significantly associated with the response to NSC 615035; 3) Molecule: the relationships between components within communities and NSC 615035; 4) MDR: the compounds that were significantly associated with the NSC 615035.

NSC Compound Enrichment Correlation
NSC 681632 Camptothecin Derivative 0.0164116791870036 0.18920695
NSC 707085 Null 0.0164116791870036 0.12922605
NSC 727086 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-3a-pyrrolidino-5-androsten-17a-yl acetate 0.0164116791870036 0.063460356
NSC 644945 Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6-one, 5,5a,6,8,8a,9-hexahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)- 9-[2-(dimethylamino)ethoxy]-, stereoisomer, hydrochloride 0.017498903403062 0.17701663
NSC 658828 Null 0.017498903403062 0.21424818
NSC 681643 Camptothecin Derivative 0.017498903403062 0.2584205
NSC 13318 Null 0.0174989034030623 0.044519323
NSC 276371 2,5-Cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-[(3,7,11,15-tetramethyl-2-hexadecenyl)thio]-, [R-[R*,R*-(E)]]- 0.0174989034030623 -0.023842059
NSC 292206 RUSTAIYAN A 0.0174989034030623 0.16752929
NSC 29443 Null 0.0174989034030623 0.38434557
Total:48  Current:12    [First] [Prev] [Next] [Last]